SHEILA LEKANKA: Open Payments
NPI 1528644853 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 39 payments from 14 companies in 2025. Trend: 2023 $1,057 · 2024 $1,887 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 6 | $102 |
| Alnylam Pharmaceuticals Inc. | 5 | $90 |
| Amgen Inc. | 4 | $74 |
| Kestra Medical Technology Services, Inc. | 2 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $51 |
| PFIZER INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
Products named: LEQVIO, ONPATTRO, REPATHA, CAMZYOS, Assure WCD, LifeVest, VYNDAQEL, AREXVY.
Industry payments across NY — which companies pay providers there.
